COPENHAGEN, Denmark, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in a fireside chat at the TD Cowen 45th Annual ...
With the popular social media app once again at risk of going dark, there are best practices pharma brands can use on other ...
HERZLIYA, Israel and CALGARY, AB, March 7, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it has closed its ...
with the pills branded with Aveo’s logo. “Aveo Pharmaceuticals, India, is also implicated in the manufacture of high-dose tramadol for export to West African countries, including Nigeria ...
A general view of the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia September 30, 2014. REUTERS/Tami Chappell/File Photo Former Republican Representative ...
Ginkgo Bioworks Holdings Inc (NYSE:DNA) added 31 new programs and contracts in Q4 2024, including five new large pharma logos and seven new data points contracts. The company has made significant ...
Ginkgo Bioworks Holdings Inc (NYSE:DNA) added 31 new programs and contracts in Q4 2024, including five new large pharma logos and seven new data points contracts. The company has made significant ...
It spans pharmaceuticals, hospital systems ... red-carpet photos in front of a step-and-repeat banner emblazoned with logos of corporate sponsors. Guests snacked on canapés and hors d’oeuvres ...
We are very pleased that we've been able to continue the momentum with our biopharma customer base, including 5 new large pharma logos and 7 new data points contracts. Now going forward ...
Weleda refreshes its brand identity, reaffirming its Swiss roots to appeal to new audiences and strengthen its premium positioning.
CordenPharma and Viking Therapeutics sign multi-year strategic partnership to support the commercial demand of Viking Therapeutics' GLP-1 drug candidate VK2735.CordenPharma provides large-scale ...
Endo achieved 2024 revenues and adjusted EBITDA expectations, while progressing the Company's strategic prioritiesXIAFLEX® hit record revenues of $516 million in 2024, up 9% versus 2023The Company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results